US Pharma MarketingEli Lilly has paused an obesity awareness campaign in India in response to a regulatory notice about the rules on advertising prescription medicines, Reuters reports.
Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report
Eli Lilly pauses Indian obesity awareness campaign after regulatory notices: report is a pharma and life sciences industry update from FiercePharma. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: FiercePharma